Filing Details

Accession Number:
0000950170-24-003133
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-08 19:30:15
Reporting Period:
2024-01-04
Accepted Time:
2024-01-08 19:30:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1618756 Restaurant Brands International Inc. QSR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1594977 Mr Axel Schwan 130 King Street West
Suite 300
Toronto A6 M5X 1E1
Pres., Tim Hortons Americas No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2024-01-04 123 $0.00 125,338 No 4 A Direct
Common Shares Disposition 2024-01-05 9,207 $76.55 116,130 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Restricted Share Units Acquisiton 2024-01-04 22 $0.00 22 $0.00
Common Shares Performance Share Units Acquisiton 2024-01-04 330 $0.00 330 $0.00
Common Shares Restricted Share Units Acquisiton 2024-01-04 16 $0.00 16 $0.00
Common Shares Performance Share Units Acquisiton 2024-01-04 212 $0.00 212 $0.00
Common Shares Restricted Share Units Acquisiton 2024-01-04 53 $0.00 53 $0.00
Common Shares Performance Share Units Acquisiton 2024-01-04 302 $0.00 302 $0.00
Common Shares Restricted Share Units Acquisiton 2024-01-04 87 $0.00 87 $0.00
Common Shares Performance Share Units Acquisiton 2024-01-04 544 $0.00 544 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,137 No 4 A Direct
46,212 No 4 A Direct
2,174 No 4 A Direct
29,692 2024-02-19 2024-02-19 No 4 A Direct
7,451 No 4 A Direct
42,299 2025-02-25 2025-02-25 No 4 A Direct
12,136 No 4 A Direct
76,136 2026-02-22 2026-02-22 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Shares Option (Right to Buy) $58.44 2028-02-22 40,000 40,000 Direct
Common Shares Option (Right to Buy) $64.75 2024-02-22 2029-02-21 30,000 30,000 Direct
Common Shares Option (Right to Buy) $66.31 2025-02-21 2030-02-20 56,000 56,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-02-22 40,000 40,000 Direct
2029-02-21 30,000 30,000 Direct
2030-02-20 56,000 56,000 Direct
Footnotes
  1. Represents shares settled from dividend equivalent rights that accrued on a vested restricted share unit award in respect of dividends that were paid after the vesting of the award with a record date prior to the vesting of the award.
  2. Represents shares sold to cover withholding tax obligations on the settlement of the previously reported vesting of the Reporting Person's restricted share units.
  3. Each restricted share unit represents a contingent right to receive one common share.
  4. Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate.
  5. These restricted share units vest on December 31, 2024.
  6. The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date.
  7. Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the performance baserd restricted share units to which they relate.
  8. These restricted share units vest in equal installments on December 31, 2021, December 31, 2022 and December 2023.
  9. These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024.
  10. The shares reported represent an award of performance based restricted share untes ("2021 PBRSUs") granted to the Reporting Person. The 2021 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2023 and to the extent earned will vest on February 19, 2024. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
  11. These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025.
  12. The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
  13. These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026.
  14. The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition.
  15. These options are fully vested and exercisable.